Purdue Pharma L.P. v. Accord Healthcare Inc. OxyContin® (Oxycodone HCl)

Case Name: Purdue Pharma L.P. v. Accord Healthcare Inc., No. 20-1362-RGA, 2023 WL 2894939 (D. Del. Apr. 11, 2023) (Andrews, J.) Drug Product and Patent(s)-in-Suit: OxyContin® (oxycodone HCl); U.S. Patents Nos. 9,763,933 (“the ’63933 patent”), 9,775,808 (“the ’808 patent”), and 9,763,886 (“the ’886 patent”), collectively “the Abuse-Deterrent patents,” 9,073,933 (“the ’73933 patent”), and 9,522,919 (“the ’919 patent”), together “the Low ABUK patents”….
By: Robins Kaplan LLP